The supporting evidence is that IP-10, which is higher in the group with prediabetes or T2DM at the sixth year, attracts pro-inflammatory immune effectors to the liver, without antiviral activity against HBV [10,46]. This evidence concerns the gene CXCL10 and type 2 diabetes mellitus.